BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 25251606)

  • 1. Improvement of biochemical and behavioral defects in the Niemann-Pick type A mouse by intraventricular infusion of MARCKS.
    Trovò L; Stroobants S; D'Hooge R; Ledesma MD; Dotti CG
    Neurobiol Dis; 2015 Jan; 73():319-26. PubMed ID: 25251606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracerebroventricular infusion of acid sphingomyelinase corrects CNS manifestations in a mouse model of Niemann-Pick A disease.
    Dodge JC; Clarke J; Treleaven CM; Taksir TV; Griffiths DA; Yang W; Fidler JA; Passini MA; Karey KP; Schuchman EH; Cheng SH; Shihabuddin LS
    Exp Neurol; 2009 Feb; 215(2):349-57. PubMed ID: 19059399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sphingomyelin-induced inhibition of the plasma membrane calcium ATPase causes neurodegeneration in type A Niemann-Pick disease.
    Pérez-Cañamás A; Benvegnù S; Rueda CB; Rábano A; Satrústegui J; Ledesma MD
    Mol Psychiatry; 2017 May; 22(5):711-723. PubMed ID: 27620840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropathology of the acid sphingomyelinase knockout mouse model of Niemann-Pick A disease including structure-function studies associated with cerebellar Purkinje cell degeneration.
    Macauley SL; Sidman RL; Schuchman EH; Taksir T; Stewart GR
    Exp Neurol; 2008 Dec; 214(2):181-92. PubMed ID: 18778708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations of myelin-specific proteins and sphingolipids characterize the brains of acid sphingomyelinase-deficient mice, an animal model of Niemann-Pick disease type A.
    Buccinnà B; Piccinini M; Prinetti A; Scandroglio F; Prioni S; Valsecchi M; Votta B; Grifoni S; Lupino E; Ramondetti C; Schuchman EH; Giordana MT; Sonnino S; Rinaudo MT
    J Neurochem; 2009 Apr; 109(1):105-15. PubMed ID: 19187445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological reversion of sphingomyelin-induced dendritic spine anomalies in a Niemann Pick disease type A mouse model.
    Arroyo AI; Camoletto PG; Morando L; Sassoe-Pognetto M; Giustetto M; Van Veldhoven PP; Schuchman EH; Ledesma MD
    EMBO Mol Med; 2014 Mar; 6(3):398-413. PubMed ID: 24448491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraparenchymal injections of acid sphingomyelinase results in regional correction of lysosomal storage pathology in the Niemann-Pick A mouse.
    Yang WW; Dodge JC; Passini MA; Taksir TV; Griffiths D; Schuchman EH; Cheng SH; Shihabuddin LS
    Exp Neurol; 2007 Oct; 207(2):258-66. PubMed ID: 17686472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonclinical safety assessment of recombinant human acid sphingomyelinase (rhASM) for the treatment of acid sphingomyelinase deficiency:the utility of animal models of disease in the toxicological evaluation of potential therapeutics.
    Murray JM; Thompson AM; Vitsky A; Hawes M; Chuang WL; Pacheco J; Wilson S; McPherson JM; Thurberg BL; Karey KP; Andrews L
    Mol Genet Metab; 2015 Feb; 114(2):217-25. PubMed ID: 25092414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Injection of mouse and human neural stem cells into neonatal Niemann-Pick A model mice.
    Sidman RL; Li J; Stewart GR; Clarke J; Yang W; Snyder EY; Shihabuddin LS
    Brain Res; 2007 Apr; 1140():195-204. PubMed ID: 17289003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sphingomyelin 16:0 is a therapeutic target for neuronal death in acid sphingomyelinase deficiency.
    Gaudioso Á; Jiang X; Casas J; Schuchman EH; Ledesma MD
    Cell Death Dis; 2023 Apr; 14(4):248. PubMed ID: 37024473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defects in sarcolemma repair and skeletal muscle function after injury in a mouse model of Niemann-Pick type A/B disease.
    Michailowsky V; Li H; Mittra B; Iyer SR; Mazála DAG; Corrotte M; Wang Y; Chin ER; Lovering RM; Andrews NW
    Skelet Muscle; 2019 Jan; 9(1):1. PubMed ID: 30611303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AAV vector-mediated correction of brain pathology in a mouse model of Niemann-Pick A disease.
    Passini MA; Macauley SL; Huff MR; Taksir TV; Bu J; Wu IH; Piepenhagen PA; Dodge JC; Shihabuddin LS; O'Riordan CR; Schuchman EH; Stewart GR
    Mol Ther; 2005 May; 11(5):754-62. PubMed ID: 15851014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acid sphingomyelinase, cell membranes and human disease: lessons from Niemann-Pick disease.
    Schuchman EH
    FEBS Lett; 2010 May; 584(9):1895-900. PubMed ID: 19944693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurons regulate the esterification of bioactive lipid mediators in the brain of acid sphingomyelinase deficient mice.
    Taha AY; Gaudioso Á; Moran-Garrido M; Camunas-Alberca SM; Bachiller-Hernández J; Sáiz J; Ledesma MD; Barbas C
    Prog Neuropsychopharmacol Biol Psychiatry; 2024 Feb; 129():110896. PubMed ID: 37956788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infusion of recombinant human acid sphingomyelinase into niemann-pick disease mice leads to visceral, but not neurological, correction of the pathophysiology.
    Miranda SR; He X; Simonaro CM; Gatt S; Dagan A; Desnick RJ; Schuchman EH
    FASEB J; 2000 Oct; 14(13):1988-95. PubMed ID: 11023983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of novel biomarkers for Niemann-Pick disease using gene expression analysis of acid sphingomyelinase knockout mice.
    Dhami R; Passini MA; Schuchman EH
    Mol Ther; 2006 Mar; 13(3):556-64. PubMed ID: 16214420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene transfer of human acid sphingomyelinase corrects neuropathology and motor deficits in a mouse model of Niemann-Pick type A disease.
    Dodge JC; Clarke J; Song A; Bu J; Yang W; Taksir TV; Griffiths D; Zhao MA; Schuchman EH; Cheng SH; O'Riordan CR; Shihabuddin LS; Passini MA; Stewart GR
    Proc Natl Acad Sci U S A; 2005 Dec; 102(49):17822-7. PubMed ID: 16301517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain pathology in Niemann Pick disease type A: insights from the acid sphingomyelinase knockout mice.
    Ledesma MD; Prinetti A; Sonnino S; Schuchman EH
    J Neurochem; 2011 Mar; 116(5):779-88. PubMed ID: 21214563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AAV8-mediated hepatic expression of acid sphingomyelinase corrects the metabolic defect in the visceral organs of a mouse model of Niemann-Pick disease.
    Barbon CM; Ziegler RJ; Li C; Armentano D; Cherry M; Desnick RJ; Schuchman EH; Cheng SH
    Mol Ther; 2005 Sep; 12(3):431-40. PubMed ID: 16099409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Types A and B Niemann-Pick disease.
    Schuchman EH; Wasserstein MP
    Best Pract Res Clin Endocrinol Metab; 2015 Mar; 29(2):237-47. PubMed ID: 25987176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.